Biomarker name | Clinical application | Expression pattern | PMID | Link |
---|---|---|---|---|
glycine | upregulated | treatment(novel target) | 34099314 | View |
16α-OHE1 -ERα | high-affinity antigen for EC antibodies | diagnosis | 32761720 | View |
estriol (E3) | upregulated | prognosis(unfavorable) | 29092787 | View |
estrone-sulfate (E1-S) | upregulated | prognosis(unfavorable) | 29092787 | View |
4-methoxy-E2 (4MeO-E2) | upregulated | prognosis(unfavorable) | 29092787 | View |
neopterin | upregulated | diagnosis | 28383326 | View |
4-OHE2 | upregulated | diagnosis(risk of estrogen-induced endometrial cancer) | 24722971 | View |
2,3-Pyridinedicarboxylic acid | upregulated | diagnosis | 36510632 | View |
Hematommic acid, ethyl ester | upregulated | diagnosis | 36510632 | View |
Maltitol | upregulated | diagnosis | 36510632 | View |
13(S)-HODE | upregulated | diagnosis | 36510632 | View |
serine | upregulated | treatment(novel target) | 34099314 | View |
D-Mannitol | upregulated | diagnosis | 36510632 | View |
ursodeoxycholic acid | upregulated | diagnosis | 36799979 | View |
PC(O-14:0_20:4) | upregulated | diagnosis | 36799979 | View |
Cer(d18:1/18:0) | upregulated | diagnosis | 36799979 | View |
SM C18:0 | upregulated | treatment(novel target) | 34099314 | View |
free carnitine | upregulated | treatment(novel target) | 34099314 | View |
C22-ceramides | upregulated | diagnosis | 33360772 | View |
C16-ceramide | upregulated | diagnosis | 33360772 | View |
hydroxyhexadecenoylcarnitine | upregulated | diagnosis | 33360772 | View |
1-methyladenosine | upregulated | diagnosis | 33360772 | View |
C22-ceramides+C16-ceramide+hydroxyhexadecenoylcarnitine+1-methyladenosine | upregulated | diagnosis | 33360772 | View |